Skip to main content
logo
Roche Holding AG (LON:0QQ6)
London flag London · Delayed Price · Currency is GBP · Price in CHF
279.20
+2.22 (0.80%)
At close: Nov 7, 2025

Revenue

Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212011 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2011 - 2020
Roche Pharmaceuticals Revenue
44.59B43.30B
Log In
Log In
Log In
Upgrade
Chugai Revenue
2.93B2.87B
Log In
Log In
Log In
Upgrade
Pharmaceuticals Revenue
47.52B46.17B
Log In
Log In
Log In
Upgrade
Diagnostics Revenue
14.07B14.32B
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212011 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2011 - 2020
Switzerland Revenue
-747.00M
Log In
Log In
Log In
Upgrade
Germany Revenue
-2.93B
Log In
Log In
Log In
Upgrade
Rest of Europe Revenue
-10.29B
Log In
Log In
Log In
Upgrade
Europe Revenue
-13.97B
Log In
Log In
Log In
Upgrade
United States Revenue
-28.90B
Log In
Log In
Log In
Upgrade
Rest of North America Revenue
-889.00M
Log In
Log In
Log In
Upgrade
North America Revenue
-29.79B
Log In
Log In
Log In
Upgrade
Latin America Revenue
-3.25B
Log In
Log In
Log In
Upgrade
Japan Revenue
-3.15B
Log In
Log In
Log In
Upgrade
Rest of Asia Revenue
-9.09B
Log In
Log In
Log In
Upgrade
Asia Revenue
-12.24B
Log In
Log In
Log In
Upgrade
Africa, Australia and Oceania Revenue
-1.25B
Log In
Log In
Log In
Upgrade

EBIT

Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212011 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2011 - 2020
Roche Pharmaceuticals Operating Profit
14.13B12.34B
Log In
Log In
Log In
Upgrade
Chugai Operating Profit
3.16B3.21B
Log In
Log In
Log In
Upgrade
Pharmaceuticals Operating Profit
17.63B15.59B
Log In
Log In
Log In
Upgrade
Diagnostics Operating Profit
1.24B1.95B
Log In
Log In
Log In
Upgrade
Corporate Operating Profit
-4.19B-4.12B
Log In
Log In
Log In
Upgrade

Capital Expenditures

Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212011 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2011 - 2020
Roche Pharmaceuticals Capital Expenditures
4.98B6.00B
Log In
Log In
Log In
Upgrade
Chugai Capital Expenditures
476.00M350.00M
Log In
Log In
Log In
Upgrade
Pharmaceuticals Capital Expenditures
5.45B6.35B
Log In
Log In
Log In
Upgrade
Diagnostics Capital Expenditures
2.45B2.44B
Log In
Log In
Log In
Upgrade
Corporate Capital Expenditures
66.00M78.00M
Log In
Log In
Log In
Upgrade
Updated Jun 30, 2025. Data Source: Fiscal.ai.